Medicare Enrolled

Dr. Michele Tagliati, M.D.

Neurology · Los Angeles, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
127 S. SAN VICENTE BLVD., A-6600, Los Angeles, CA 90048
3104236472
In practice since 2006 (20 years)
NPI: 1134190457 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Tagliati from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Tagliati? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Tagliati

Dr. Michele Tagliati is a neurology specialist in Los Angeles, CA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Tagliati performed 1,453 Medicare services across 799 unique beneficiaries.

Between the years covered by Open Payments, Dr. Tagliati received a total of $340,725 from 25 pharmaceutical and/or device companies across 514 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Tagliati is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 25% volume in CA $340,725 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,453
Medicare services
Top 25% in CA for neurology
799
Unique beneficiaries
$77
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~73 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
468 $113 $466
Needle measurement of electrical activity in muscle with injection of chemical for paralysis of nerve muscle 193 $16 $64
Chemical nerve block for neck muscles
Injection of a chemical agent to paralyze specific muscles on the side of the neck, excluding the voice box.
128 $78 $370
Brain stimulator programming, additional 15 minutes
Electronic analysis and programming of an implanted brain neurostimulator generator by a qualified health professional. This code applies to each additional 15-minute increment beyond the initial service.
106 $34 $141
New patient office visit, complex (60-74 min) 105 $146 $608
Chemical nerve block injection, 1-4 muscles
An injection of a chemical agent to paralyze specific muscles in an arm or leg. This procedure targets one to four muscles in the first extremity treated.
102 $64 $406
Prolonged office E/M service, first 15 minutes
This code is used for additional time spent by a physician beyond the maximum required time of a primary office or outpatient evaluation and management service. It is billed in 15-minute increments based on total time spent on the date of the primary service.
75 $26 $102
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
61 $80 $322
Injection of chemical for paralysis of nerve muscles on arm or leg, 1-4 muscles, each additional extremity 55 $56 $267
Brain stimulator programming, first 15 minutes
Electronic analysis of an implanted brain, spinal cord, or peripheral neurostimulator generator. This service includes programming the brain stimulator by a qualified health professional for the first 15 minutes.
53 $38 $160
Chemical paralysis of salivary glands, bilateral
Injection of a chemical agent to paralyze the salivary glands on both sides of the mouth.
37 $93 $370
Chemical nerve block for facial paralysis
Injection of a chemical agent to paralyze specific nerves or muscles on the side of the face.
30 $99 $500
Electronic analysis of implanted neurostimulator
Electronic evaluation of an implanted brain, spinal cord, or peripheral nerve stimulator device.
24 $15 $198
Initial hospital admission, moderate complexity
Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter.
16 $111 $422
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$340,725
Total received (2018-2024)
Avg $48,675/year across 7 years
Top 2% in CA for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
25
Companies
514
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$273,950 (80.4%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$58,883 (17.3%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,892 (2.3%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$30,017
2023
$33,180
2022
$30,051
2021
$24,968
2020
$45,614
2019
$89,253
2018
$87,643

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Boston Scientific Corporation
$20,840
MITSUBISHI TANABE PHARMA AMERICA, INC.
$4,644
MDD US Operations, LLC
$2,760
ABBVIE INC.
$1,057
Medtronic, Inc.
$247
Acorda Therapeutics, Inc
$212
Neurocrine Biosciences, Inc.
$111
Abbott Laboratories
$80
Merz Pharmaceuticals, LLC
$52
Amneal Pharmaceuticals LLC
$14
Top 3 companies account for 94.1% of 2024 payments
All-time payments by company (2018-2024) ›
Boston Scientific Corporation
$132,631
Medtronic USA, Inc.
$90,715
Abbott Laboratories
$53,852
BOSTON SCIENTIFIC CORPORATION
$24,043
AbbVie Inc.
$9,846
MDD US Operations, LLC
$5,098
Allergan, Inc.
$4,794
MITSUBISHI TANABE PHARMA AMERICA, INC.
$4,644
Acorda Therapeutics, Inc
$4,353
ABBVIE INC.
$3,956
Kyowa Kirin, Inc.
$2,250
Biogen, Inc.
$1,013
Medtronic, Inc.
$876
Sage Therapeutics, Inc.
$832
Merz Pharmaceuticals, LLC
$612
US WorldMeds, LLC
$544
MERZ NORTH AMERICA, INC.
$185
ACADIA Pharmaceuticals Inc
$142
Neurocrine Biosciences, Inc.
$111
Merz North America, Inc.
$96
F. Hoffmann-La Roche AG
$48
Allergan Inc.
$39
Cala Health, Inc.
$31
Amneal Pharmaceuticals LLC
$14
Travere Therapeutics, Inc.
$1
Top 3 companies account for 81.4% of all-time payments
Associated products mentioned in payments ›
ACTIVA · ACTIVA PC · APOKYN · Apokyn · BOTOX · CALA TRIO · Cholbam · DUOPA · Deep Brain Stimulation · EMBLEM MRI S-ICD · GENERAL DBS · GENERAL DBS · GENERAL THERAPIES · GENERAL - DBS · GENERAL DBS · General - DBS · INBRIJA · INFINITY · INGREZZA · Infinity DBS Pulse Generators · MYOBLOC · NUPLAZID · Neuromodulation Dspsbls and Accs · Nourianz · PERCEPT PC BRAINSENSE · PROCLAIM · QULIPTA · RYTARY · SPECTRA WAVEWRITER · THERAPIES · VERCISE · VYALEV · Vercise · XADAGO · XEOMIN · Xadago · Xeomin
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (80%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in neurology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 2% for neurology in CA.

Looking for a neurology specialist in Los Angeles?
Compare neurologists in the Los Angeles area by procedure volume, costs, and industry payment transparency.
Browse neurologists nearby

Geographic Context

Neurologists within 10 mi
548
Per 100K population
5.6
County median income
$87,760
Nearest hospital
CEDARS-SINAI MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Tagliati is a clinical cardiology specialist, with above-average Medicare volume (top 25% in CA), with speaking/promotional industry engagement in the top 2% of CA peers, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Tagliati experienced with office visit, established patient, complex (40-54 min)?
Based on Medicare claims data, Dr. Tagliati performed 468 office visit, established patient, complex (40-54 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Tagliati receive payments from pharmaceutical companies?
Yes. Dr. Tagliati received a total of $340,725 from 25 companies across 514 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Tagliati's costs compare to other neurologists in Los Angeles?
Dr. Tagliati's average Medicare payment per service is $77. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Tagliati) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →